Funder: European Commission
Due Dates: April 12, 2027 | April 13, 2027
Funding Amounts: €8–10 million per project | Up to 5 grants expected | 100% funding rate (RIA)
Summary: Funds the development of innovative antibacterial and antifungal therapies targeting drug-resistant pathogens to address antimicrobial resistance and strengthen the EU's research leadership.
Key Information: Proposals must target one specific high-priority pathogen and include a clear regulatory pathway; legal entities from China are not eligible.